MedTrace Logo

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

NCT05990478 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-05-21

No results posted yet for this study

Summary

The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of residual disease in the breast following neoadjuvant treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

Contrast-Enhanced Mammography

Participants will have pre- and post-treatment CEM of the affected breast

DIAGNOSTIC_TEST

Breast MRI

Pre- and post-NAT breast MRI will be performed for all participants

Sponsors & Collaborators

Principal Investigators

  • Joao Machado Horvat, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-03
Primary Completion
2024-07-26
Completion
2024-07-26

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05990478 on ClinicalTrials.gov